Clinical Trial

Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission

Study acronym: IDEA
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
IDEA is a Phase IV, prospective, randomised, open-label, multicentre clinical trial designed to evaluate the safety and efficacy of withdrawing thiopurines in elderly (≥60 years) patients with ulcerative colitis (UC) who are in sustained clinical and biological remission. The study compares discontinuation of thiopurines versus continuation while maintaining background mesalamine therapy over 24 months of treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-18.
Trial Details
NCT Number NCT07248644
Lead Sponsor Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Conditions Ulcerative Colitis (UC)
Enrollment 304 participants
Start Date 2026-05-01
Primary Completion 2026-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-04-15